Zobrazeno 1 - 10
of 54
pro vyhledávání: '"Peter J. Jewesson"'
Autor:
Lionel A Mandell, Michel G Bergeron, Marie J Gribble, Peter J Jewesson, Donald E Low, Thomas J Marrie, Lindsay E Nicolle
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 6, Iss 6, Pp 306-315 (1995)
The escalating costs associated with antimicrobial chemotherapy have become of increasing concern to physicians, pharmacists and patients alike. A number of strategies have been developed to address this problem. This article focuses specifically on
Externí odkaz:
https://doaj.org/article/fcb866a84da3455785e1d3b8c209ae9d
Autor:
Peter J Jewesson
Publikováno v:
Canadian Journal of Infectious Diseases, Vol 6, Iss Suppl A, Pp 11A-16A (1995)
Parenteral to oral stepdown therapy represents an effective cost containment strategy which can minimize intravenous therapy associated morbidity and may facilitate earlier hospital discharge. Several oral anti-infectives are available to the prescri
Externí odkaz:
https://doaj.org/article/5ce1e48ed7ff4255904bbbb5a85a7ea7
Publikováno v:
American Journal of Health-System Pharmacy. 62:1782-1787
Purpose. A scalable, multiuser, personal digital assistant (PDA)-based documentation tool for pharmacist collection of data on drug-related problems (DRPs) is described. Summary. A PDA-based tool for documenting DRPs and pharmacist interventions was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d55e6a75b3bed20f3b538d7954ef901
https://doi.org/10.2146/ajhp040438
https://doi.org/10.2146/ajhp040438
Autor:
Susan S Buchkowsky, Peter J. Jewesson
Publikováno v:
Annals of Pharmacotherapy. 38:579-585
BACKGROUND The pharmaceutical industry has become a major source of funding for biomedical research. Our general observation is that pharmaceutical industry employees are appearing with increasing frequency as coauthors of clinical trial publications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6594a5909cb4e3f88680d64dd2cf193
https://doi.org/10.1345/aph.1d267
https://doi.org/10.1345/aph.1d267
Autor:
Peter J Jewesson, T Laine Bosma
Publikováno v:
Journal of Infusion Nursing. 25:310-315
Infusion resource teams are comprised of nurses specially trained and experienced in infusion therapy. Our multidisciplinary team provides clinical, educational, and research support to a 1000-bed Canadian tertiary hospital. To characterize the infus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a45299d0bbbaec2a55fb2b2b9dbd837e
https://doi.org/10.1097/00129804-200209000-00004
https://doi.org/10.1097/00129804-200209000-00004
Publikováno v:
American Journal of Health-System Pharmacy. 59:1453-1456
D., isPharmacotherapeutic Specialist—EmergencyMedicine, Clinical Services Unit Pharmaceu-tical Sciences, Vancouver Hospital and HealthSciences Centre (VHHSC), and Clinical Assis-tant Professor, Faculty of Pharmaceutical Sci-ences, University of Bri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::349a7aeacf3cd5961c656e5ec2a963d7
https://doi.org/10.1093/ajhp/59.15.1453
https://doi.org/10.1093/ajhp/59.15.1453
Publikováno v:
Clinical drug investigation. 12(2)
The recent increase in the use of vancomycin has led to renewed interest in its pharmacokinetics, and, in particular, the importance of monitoring serum drug concentrations. A review of the literature and evaluation of pharmacokinetic data from Vanco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860030ef307e0d69fbf139338af30f04
https://pubmed.ncbi.nlm.nih.gov/24610671
https://pubmed.ncbi.nlm.nih.gov/24610671
Publikováno v:
PharmacoEconomics. 18:451-457
Background: Outpatient parenteral antibiotic therapy (OPAT) programmes have become prevalent over the past 2 decades. From the US perspective, these programmes have been shown to reduce healthcare costs. No comprehensive analysis has been published f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::edda2c7cc4e3e010d2b0901c8adb10fb
https://doi.org/10.2165/00019053-200018050-00004
https://doi.org/10.2165/00019053-200018050-00004
Autor:
D. I. Warkentin, Luciana Frighetto, Carlo A. Marra, Peter J. Jewesson, M. L. De Lemos, C. B. Quaia, Fawziah Marra
Publikováno v:
Pharmacotherapy. 20:931-940
Study Objective. To determine treatment outcomes and economic impact of a ciprofloxacin stepdown program for high-risk febrile neutropenic adults from the hospital's perspective. Design. Unblinded, two-phase, single-center study. Setting. Adult leuke
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9658d4386c29345bb03bdc8e119ba0c
https://doi.org/10.1592/phco.20.11.931.35258
https://doi.org/10.1592/phco.20.11.931.35258
Autor:
Luciana Frighetto, Elizabeth A Bryce, Robert P. Reynolds, Kenna Sleigh, Carlo A. Marra, Fawziah Marra, Peter J. Jewesson, H Grant Stiver
Publikováno v:
Annals of Pharmacotherapy. 33:156-162
BACKGROUND: In 1998 we reported the first Canadian double-blind, randomized, clinical trial involving a comparison of piperacillin/tazobactam (P/T) with imipenem/cilastatin (I/C). The present study was conducted to determine the feasibility of replac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f99ada790579f3c60cab77f964dd3a4e
https://doi.org/10.1345/aph.17366
https://doi.org/10.1345/aph.17366